Health · Silver Spring, Maryland · United States of America · November 10, 2026

FDA adds eye risk warning to GLP-1 drugs

Reported by 1 outlet · first reported Nov 10, 12:00 PM ET

The US Food and Drug Administration added a warning about eye risks to GLP-1 weight-loss and diabetes drugs. The label change applies to products such as Ozempic and Mounjaro.

Sources

• BBC News ↗Nov 10, 12:00 PM ET

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.

See it on the globe →All of Nov 10's stories